Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: J Immunol. 2015 Jan 26;194(5):2415–2423. doi: 10.4049/jimmunol.1402623

Figure 2. RA-DCs release tolerogenic cytokines.

Figure 2

The fold increase (mean ± SEM, n=8) in the concentration of the indicated soluble factors in the supernatants of RA-DCs are shown compared to the control moDCs (set as 1) at day 6 of culture. The data from 1 donor were excluded for TGF-β1, because this donor had 4-fold less TGF-β1 in RA-DCs than in moDCs. This was in contrast with all other donors showing the opposite trend (*p<0.05; **p<0.01; ***p<0.001).